Ftse Mib
34.339,32
0,00%
DAX
18.686,60
1,07%
S&P 500
5.214,08
0,51%
NASDAQ
16.346,26
0,27%
Bitcoin
62.963,83
-0,13%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. USOTC Astellas Pharma Inc (PK) (ALPMY) Astellas Pharma Inc (PK) (ALPMY) Notizie

ALPMY

Astellas Pharma (PK) (ALPMY)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:USOTC:ALPMY
DataOraFonteTitoloSimboloCompagnia
15/12/202323:53Dow Jones NewsMerck, Pfizer, Astellas Get FDA OK For Expanded Use Of Keytruda Plus PadcevUSOTC:ALPMYAstellas Pharma Inc (PK)
01/12/202300:04Dow Jones NewsAstellas, Seagen: Cancer Treatment Padcev Supplemental Biologics License Application Gets FDA Priority ReviewUSOTC:ALPMYAstellas Pharma Inc (PK)
22/09/202313:02Dow Jones NewsMerck, Seagen, Astellas Phase 3 Bladder Cancer Study Hits EndpointsUSOTC:ALPMYAstellas Pharma Inc (PK)
07/08/202316:41Dow Jones NewsPoseida Therapeutics Shares Leap on Astellas InvestmentsUSOTC:ALPMYAstellas Pharma Inc (PK)
07/08/202315:58Dow Jones NewsPoseida Therapeutics in $50 Million Investment Deal With AstellasUSOTC:ALPMYAstellas Pharma Inc (PK)
01/05/202302:57Dow Jones NewsAstellas Pharma to Buy Iveric Bio for About $5.9 BillionUSOTC:ALPMYAstellas Pharma Inc (PK)
09/01/202316:49Dow Jones NewsSelecta Biosciences Shares Rise 11% After Licensing Deal With Astellas PharmaUSOTC:ALPMYAstellas Pharma Inc (PK)
25/10/202212:26Dow Jones NewsTaysha Gene Therapies Shares Soar Premarket on Astellas InvestmentUSOTC:ALPMYAstellas Pharma Inc (PK)
28/06/202216:28Dow Jones NewsSutro Biopharma Shares Rise 24% After Collaboration With Astellas PharmaUSOTC:ALPMYAstellas Pharma Inc (PK)
28/06/202202:37Dow Jones NewsSutro Biopharma Shares Soar 67% on Cancer Treatment Collaboration with AstellasUSOTC:ALPMYAstellas Pharma Inc (PK)
13/04/202218:31Dow Jones NewsEuropean Commission Approves Drug for Urothelial CancerUSOTC:ALPMYAstellas Pharma Inc (PK)
17/12/202113:37Dow Jones NewsAstellas Pharma, Seagen Get CHMP Positive Opinion for PadcevUSOTC:ALPMYAstellas Pharma Inc (PK)
11/08/202113:54Dow Jones NewsFDA Rejects FibroGen's Roxadustat for Anemia of Chronic Kidney DiseaseUSOTC:ALPMYAstellas Pharma Inc (PK)
21/12/201722:17Edgar (US Regulatory)Securities Registration (ads, Immediate) (f-6ef)USOTC:ALPMYAstellas Pharma Inc (PK)
29/09/201719:03Edgar (US Regulatory)Post-effective Amendment to a Previously Filed F-6. (f-6 Pos)USOTC:ALPMYAstellas Pharma Inc (PK)
22/08/201614:50Dow Jones NewsPfizer Adds Key Cancer Drug in $14 Billion Biotech DealUSOTC:ALPMYAstellas Pharma Inc (PK)
09/07/201609:02Dow Jones NewsCorrections & Amplifications -- WSJUSOTC:ALPMYAstellas Pharma Inc (PK)
07/07/201607:20Dow Jones NewsTest Aids Prostate Cancer TreatmentUSOTC:ALPMYAstellas Pharma Inc (PK)
02/06/201600:40Dow Jones NewsSanofi Asks for Record Date for Vote on Medivation's BoardUSOTC:ALPMYAstellas Pharma Inc (PK)
29/04/201600:10Dow Jones NewsDrugmakers Place Big Bets on Cancer MedicinesUSOTC:ALPMYAstellas Pharma Inc (PK)
29/03/201616:50Dow Jones NewsLawmakers Target Medivation Over Drug PricesUSOTC:ALPMYAstellas Pharma Inc (PK)
04/12/201522:03The Motley FoolOcata Therapeutics Almost Doubled in November -- Here's WhyUSOTC:ALPMYAstellas Pharma Inc (PK)
25/11/201515:04The Motley FoolJohnson & Johnson's Latest FDA Approval Could Spell Problems for AmgenUSOTC:ALPMYAstellas Pharma Inc (PK)
23/11/201516:07The Motley Fool3 Value Stocks Near 52-Week Lows Worth BuyingUSOTC:ALPMYAstellas Pharma Inc (PK)
06/11/201518:40The Motley FoolMedivation Inc is Down Today -- But Why?USOTC:ALPMYAstellas Pharma Inc (PK)
02/11/201513:34The Motley Fool3 Stocks to Buy Now in BiotechUSOTC:ALPMYAstellas Pharma Inc (PK)
15/07/201520:33Dow Jones NewsAsian Shares: China Stocks Tumble as Investors Doubt Beijing's HelpUSOTC:ALPMYAstellas Pharma Inc. ADR
22/03/201512:01The Motley FoolBest One-Drug Wonder Stock for 2015USOTC:ALPMYAstellas Pharma Inc (PK)
30/01/201505:30Dow Jones NewsValeant to Buy Prostate-Cancer Drug From DendreonUSOTC:ALPMYAstellas Pharma Inc. ADS
30/01/201505:10Dow Jones NewsValeant in Deal to Buy Prostate-Cancer Drug Provenge From DendreonUSOTC:ALPMYAstellas Pharma Inc. ADS
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:USOTC:ALPMY

La tua Cronologia

BIT
BPE
Bper Banca
BIT
UCG
Unicredit
BIT
ISP
Intesa Sanpaolo
BIT
STLAM
Stellantis NV
BIT
ENEL
Enel
BIT
NEXI
Nexi S.p.A
BIT
BAMI
Banco BPM
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
PRY
Prysmian
BIT
ENI
Eni
BIT
RACE
Ferrari NV
BIT
LDO
Leonardo
BIT
STMMI
ST Microelectronics
BIT
FBK
Finecobank
BIT
TIT
Telecom Italia
BIT
SRG
Snam
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network